Your browser doesn't support javascript.
loading
A Delphi-Based Consensus Statement on the Management of Anticoagulated Patients With Botulinum Toxin for Limb Spasticity.
Boulias, Chris; Ismail, Farooq; Phadke, Chetan P; Bagg, Stephen; Bureau, Isabelle; Charest, Stephane; Chen, Robert; Cheng, Albert; Ethans, Karen; Fink, Milo; Finlayson, Heather; Gulasingam, Sivakumar; Guo, Meiqi; Haziza, Muriel; Hosseini, Hossein; Khan, Omar; Lang, Michael; Lapp, Timothy; Leckey, Robert; Li Pi Shan, Rodney; Liem, Nathania; Lo, Alexander; Mason, Mark; McNeil, Stephen; McVeigh, Sonja; Miller, Thomas; Mills, Patricia B; Naud, Pierre; O'Connell, Colleen; Petitclerc, Marc; Prevost, Julie; Reebye, Rajiv; Richardson, Denyse; Satkunam, Lalith; Sharma, Satyendra; Short, Christine; Sirois, Genevieve; Unarket, Milan; Wein, Theodore; Wilkins, Kathryn; Winston, Paul.
Affiliation
  • Boulias C; West Park Healthcare Centre, Toronto, Ontario, Canada; Physical Medicine and Rehabilitation, University of Toronto, Toronto, Ontario, Canada. Electronic address: chris.boulias@westpark.org.
  • Ismail F; West Park Healthcare Centre, Toronto, Ontario, Canada; Physical Medicine and Rehabilitation, University of Toronto, Toronto, Ontario, Canada.
  • Phadke CP; West Park Healthcare Centre, Toronto, Ontario, Canada; Department of Physical Therapy, University of Toronto, Toronto, Ontario, Canada; Graduate Program in Kinesiology and Health Science, York University, Toronto, Ontario, Canada.
  • Bagg S; Providence Care Hospital and School of Medicine, Queen's University, Kingston, Ontario, Canada.
  • Bureau I; Centre for Integrated Health and Social Service (CISSS) for Chaudière-Appalaches Region, Hôtel-Dieu de Lévis, Lévis, Québec, Canada.
  • Charest S; Spasticity Clinic, H Mauricie Center of Quebec, Trois-Rivières, Québec, Canada.
  • Chen R; University Health Network, Toronto, Ontario, Canada; Division of Neurology, University of Toronto, Toronto, Ontario, Canada.
  • Cheng A; Physical Medicine and Rehabilitation, University of Toronto, Toronto, Ontario, Canada; University Health Network, Toronto, Ontario, Canada; Providence Healthcare, Toronto, Ontario, Canada.
  • Ethans K; Winnipeg Health Sciences Centre and Physical Medicine and Rehabilitation, University of Manitoba, Winnipeg, Manitoba, Canada.
  • Fink M; Wascana Rehabilitation Centre and University of Saskatchewan, Regina, Saskatchewan, Canada.
  • Finlayson H; GF Strong Rehabilitation Center and Division of Physical Medicine and Rehabilitation, University of British Columbia, Vancouver, British Columbia, Canada.
  • Gulasingam S; Physical Medicine and Rehabilitation, University of Toronto, Toronto, Ontario, Canada; University Health Network, Toronto, Ontario, Canada.
  • Guo M; Physical Medicine and Rehabilitation, University of Toronto, Toronto, Ontario, Canada.
  • Haziza M; Physiatry Clinic, CDN Institute of Rehabilitation, Montreal, Québec, Canada.
  • Hosseini H; Regional Rehabilitation Centre, Hamilton, Ontario, Canada.
  • Khan O; Regional Rehabilitation Centre, Hamilton, Ontario, Canada; Hotel Dieu Shaver, St. Catharines, Ontario, Canada.
  • Lang M; Halton Healthcare, Milton, Ontario, Canada.
  • Lapp T; Muskoka Algonquin Health Care and Northern Ontario School of Medicine, Sudbury, Ontario, Canada.
  • Leckey R; Stan Cassidy Centre, Fredericton, New Brunswick, Canada; Division of Physical Medicine and Rehabilitation, Dalhousie University, Halifax, Nova Scotia, Canada.
  • Li Pi Shan R; Foothills Medical Centre, Calgary, Alberta, Canada; University of Calgary, Calgary, Alberta, Canada.
  • Liem N; Hôtel-Dieu Grace Healthcare, Windsor, Ontario, Canada.
  • Lo A; University Health Network, Toronto, Ontario, Canada.
  • Mason M; Oshawa Clinic, Oshawa, Ontario, Canada.
  • McNeil S; Foothills Medical Centre, Calgary, Alberta, Canada; University of Calgary, Calgary, Alberta, Canada.
  • McVeigh S; Division of Physical Medicine and Rehabilitation, Dalhousie University, Halifax, Nova Scotia, Canada; Nova Scotia Rehabilitation Centre, Halifax, Nova Scotia, Canada.
  • Miller T; St. Joseph's Health Care London, Western University, London, Ontario, Canada.
  • Mills PB; GF Strong Rehabilitation Center and Division of Physical Medicine and Rehabilitation, University of British Columbia, Vancouver, British Columbia, Canada.
  • Naud P; Capital Health Complex, Quebec City, Québec, Canada.
  • O'Connell C; Stan Cassidy Centre, Fredericton, New Brunswick, Canada; Division of Physical Medicine and Rehabilitation, Dalhousie University, Halifax, Nova Scotia, Canada.
  • Petitclerc M; Neuro-Lévis Neurology Clinic, Lévis, Québec, Canada.
  • Prevost J; Saint-Jérôme Regional Hospital, Saint-Jérôme, Québec, Canada.
  • Reebye R; GF Strong Rehabilitation Center and Division of Physical Medicine and Rehabilitation, University of British Columbia, Vancouver, British Columbia, Canada.
  • Richardson D; Physical Medicine and Rehabilitation, University of Toronto, Toronto, Ontario, Canada; University Health Network, Toronto, Ontario, Canada.
  • Satkunam L; Glenrose Rehabilitation Hospital and Division of Physical Medicine & Rehabilitation, University of Alberta, Edmonton, Alberta, Canada.
  • Sharma S; University Health Network, Toronto, Ontario, Canada; Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.
  • Short C; Division of Physical Medicine and Rehabilitation, Dalhousie University, Halifax, Nova Scotia, Canada; Nova Scotia Rehabilitation Centre, Halifax, Nova Scotia, Canada.
  • Sirois G; Quebec of Institute of Rehabilitation and Physical Impairment and Laval University, Québec City, Québec, Canada.
  • Unarket M; Physical Medicine and Rehabilitation, University of Toronto, Toronto, Ontario, Canada; University Health Network, Toronto, Ontario, Canada.
  • Wein T; Montreal General Hospital and McGill University, Montreal, Québec, Canada.
  • Wilkins K; Aviva Medical, Barrie, Ontario, Canada.
  • Winston P; CBI Health Centre, Victoria, British Columbia, Canada.
Arch Phys Med Rehabil ; 99(11): 2183-2189, 2018 11.
Article in En | MEDLINE | ID: mdl-29803825

Full text: 1 Database: MEDLINE Main subject: Botulinum Toxins, Type A / Anticoagulants / Muscle Spasticity / Neuromuscular Agents Type of study: Etiology_studies / Guideline / Prognostic_studies / Qualitative_research / Risk_factors_studies Limits: Adult / Female / Humans / Male / Middle aged Country/Region as subject: America do norte Language: En Year: 2018 Type: Article

Full text: 1 Database: MEDLINE Main subject: Botulinum Toxins, Type A / Anticoagulants / Muscle Spasticity / Neuromuscular Agents Type of study: Etiology_studies / Guideline / Prognostic_studies / Qualitative_research / Risk_factors_studies Limits: Adult / Female / Humans / Male / Middle aged Country/Region as subject: America do norte Language: En Year: 2018 Type: Article